Broadcom has a massive opportunity ahead with custom AI chips. UiPath has huge potential upside as its revenue starts to accelerate.
Source: https://www.fool.com/investing/2025/12/11/2-artificial-intel…
Axsome Therapeutics has an exciting late-stage pipeline. Madrigal Pharmaceuticals is looking to dominate a large market with significant unmet needs.
In the last three months of 2025, the tech sector experienced what some called a “correction”.
Bank of America’s network continues to expand. ExxonMobil returned $37.2 billion to shareholders in 2025, increasing its dividend yet again.
